Quality Measure Specifications and Recommended Workflows

Active

These measures are available for enrollment and are either certified, or MIE is actively pursuing certification of versions for the current measurement period.

CMS2 - Preventive Care and Screening: Screening for Depression and Follow-Up Plan

CMS22 - Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented

CMS68 - Documentation of Current Medications in the Medical Record

CMS69 - Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan

CMS117 - Childhood Immunization Status

CMS122 - Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)

CMS124 - Cervical Cancer Screening

CMS125 - Breast Cancer Screening

CMS130 - Colorectal Cancer Screening

CMS131 - Diabetes: Eye Exam

CMS138 - Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

CMS139 - Falls: Screening for Future Fall Risk

CMS155 - Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents

CMS156 - Use of High-Risk Medications in Older Adults

CMS159 - Depression Remission at Twelve Months

CMS165 - Controlling High Blood Pressure

CMS347 - Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

CMS951 - Kidney Health Evaluation

Available

These measures have been developed and are available for enrollment; however, the most recent version may not be available, and MIE is not pursuing certification for these measures. If your organization is interested in complying with a certified version of any of these measures, please contact MIE.

CMS50 - Closing the Referral Loop: Receipt of Specialist Report

CMS74 - Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists

CMS75 - Children Who Have Dental Decay or Cavities

CMS90 - Functional Status Assessments for Heart Failure

CMS134 - Diabetes: Medical Attention for Nephropathy

CMS135 - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)

CMS136 - Follow-Up Care for Children Prescribed ADHD Medication (ADD)

CMS142 - Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care

CMS144 - Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

CMS145 - Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than 40%)

CMS146 - Appropriate Testing for Pharyngitis

CMS149 - Dementia: Cognitive Assessment

CMS153 - Chlamydia Screening for Women

CMS154 - Appropriate Treatment for Upper Respiratory Infection (URI)

CMS157 - Oncology: Medical and Radiation - Pain Intensity Quantified

Retired

These measures have been retired from use in CMS reporting programs. Previous versions of these measures are still available for enrollment for any organizations interested in monitoring their compliance.

CMS127 - Pneumococcal Vaccination Status for Older Adults

CMS147 - Preventive Care and Screening: Influenza Immunization

Unavailable

These measures have not been implemented by MIE and are not available for enrollment. If your organization is interested in complying with a certified version of any of these measures, please contact MIE.

CMS56 - Functional Status Assessment for Total Hip Replacement

CMS66 - Functional Status Assessment for Total Knee Replacement

CMS128 - Anti-depressant Medication Management

CMS129 - Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients

CMS133 - Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery

CMS137 - Initiation and Engagement of Alcohol and Other Drug Dependence Treatment

CMS143 - Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation

CMS161 - Adult Major Depressive Disorder (MDD): Suicide Risk Assessment

CMS177 - Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment

CMS249 - Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture

CMS349 - HIV Screening

CMS645 - Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy

CMS646 - Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer

CMS771 - Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia